Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study-Reference-Cited by-同舟云学术

Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study

Published:2007-02 Issue:2 Volume:46 Page:206-212
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Iacobellis Angelo,Siciliano Massimo,Perri Francesco,Annicchiarico Brigida E.,Leandro Gioacchino,Caruso Nazario,Accadia Laura,Bombardieri Giuseppe,Andriulli Angelo

Publisher

Elsevier BV

Subject

Hepatology

Reference19 articles.

1. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis;Heathcote;N Engl J Med,2000

2. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach;Camma;J Hepatol,2001

3. Determinants of outcome of compensated hepatitis C virus-related cirrhosis;Serfaty;Hepatology,1998

4. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on viral hepatitis (EUROHEP);Fattovich;J Hepatol,1997

5. PEGASYS International study group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection;Problems of Virology;2021-11-04

2. Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus;Infectious Diseases and Therapy;2021-04-21

3. Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs;Medicina;2021-02-26

4. Liver-related effects of chronic hepatitis C antiviral treatment;World Journal of Gastroenterology;2020-06-14

5. Hepatitis C;Gastroenterology Clinics of North America;2020-06